Medicine & Life Sciences
Prostatic Neoplasms
100%
Castration
43%
Docetaxel
27%
Prostate-Specific Antigen
26%
Androgens
25%
Neoplasms
22%
Renal Cell Carcinoma
18%
Survival
15%
Therapeutics
15%
Progression-Free Survival
13%
Hormones
13%
Clinical Trials
13%
Atrasentan
12%
MDV 3100
11%
Prostate
11%
Pharmacokinetics
10%
Sunitinib
10%
Neoplasm Metastasis
10%
Drug Therapy
8%
abiraterone
8%
Placebos
8%
Prostatectomy
8%
Phenylbutyrates
8%
Androgen Receptors
7%
Bone and Bones
7%
Histone Deacetylase Inhibitors
7%
Safety
7%
Nivolumab
6%
Bevacizumab
5%
tasquinimod
5%
Patient Reported Outcome Measures
5%
4-phenylbutyric acid
5%
Biomarkers
5%
Estramustine
5%
bis(2,3,3,3-tetrachloropropyl) ether
5%
Quality of Life
5%
Disease Progression
5%